This is the new picture of hepatitis C’s E2 protein, which the
virus uses to infect liver cells, will aid in the design of a vaccine
against the disease. Credit: Christina Corbaci, The Scripps Research
Scientists at The Scripps Research Institute (TSRI) have determined
the most detailed picture yet of a crucial part of the hepatitis C
virus, which the virus uses to infect liver cells. The new data reveal
unexpected structural features of this protein and should greatly speed
efforts to make an effective hepatitis C vaccine.
The findings, which appear in the November 29, 2013 issue of the journal Science, focus on a protein known as E2 envelope glycoprotein.